The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing?

EuroIntervention 2016;12:Y28-Y32. DOI: 10.4244/EIJV12SYA7

Cedars-Sinai Heart Institute, Los Angeles, CA, USA

Symptomatic transcatheter heart valve (THV) thrombosis is noted in up to 1% of patients after transcatheter aortic valve replacement. Recently, hypoattenuated leaflet thickening and reduced leaflet motion of bioprosthetic aor

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Current status of transcatheter valve therapy in Europe: results from an EAPCI survey